首页 > 1 cent online slot games

tilapia fishing

2025-01-13
Natixis Advisors LLC grew its position in Merit Medical Systems, Inc. ( NASDAQ:MMSI – Free Report ) by 1.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 67,544 shares of the medical instruments supplier’s stock after purchasing an additional 1,009 shares during the quarter. Natixis Advisors LLC owned approximately 0.12% of Merit Medical Systems worth $6,675,000 as of its most recent filing with the SEC. Several other large investors also recently modified their holdings of MMSI. O Shaughnessy Asset Management LLC increased its holdings in Merit Medical Systems by 17.7% in the first quarter. O Shaughnessy Asset Management LLC now owns 3,797 shares of the medical instruments supplier’s stock worth $288,000 after purchasing an additional 572 shares in the last quarter. CANADA LIFE ASSURANCE Co lifted its position in shares of Merit Medical Systems by 5.6% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 62,343 shares of the medical instruments supplier’s stock valued at $4,724,000 after acquiring an additional 3,321 shares during the period. EntryPoint Capital LLC boosted its stake in Merit Medical Systems by 2,666.7% during the first quarter. EntryPoint Capital LLC now owns 913 shares of the medical instruments supplier’s stock worth $69,000 after acquiring an additional 880 shares in the last quarter. CreativeOne Wealth LLC grew its holdings in Merit Medical Systems by 10.3% in the first quarter. CreativeOne Wealth LLC now owns 4,003 shares of the medical instruments supplier’s stock worth $303,000 after purchasing an additional 375 shares during the period. Finally, Lazard Asset Management LLC increased its stake in Merit Medical Systems by 1,147.3% in the first quarter. Lazard Asset Management LLC now owns 7,858 shares of the medical instruments supplier’s stock valued at $594,000 after purchasing an additional 7,228 shares in the last quarter. 99.66% of the stock is currently owned by institutional investors and hedge funds. Wall Street Analysts Forecast Growth A number of equities analysts have recently issued reports on the stock. Piper Sandler reissued an “overweight” rating and set a $110.00 price objective (up previously from $100.00) on shares of Merit Medical Systems in a research report on Monday, September 9th. Bank of America raised their price objective on Merit Medical Systems from $92.00 to $103.00 and gave the company a “neutral” rating in a research note on Monday, September 16th. Needham & Company LLC reaffirmed a “buy” rating and set a $109.00 target price on shares of Merit Medical Systems in a research report on Thursday, October 31st. Barrington Research reissued an “outperform” rating and issued a $114.00 price target on shares of Merit Medical Systems in a research report on Thursday, October 31st. Finally, StockNews.com downgraded shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Sunday, November 3rd. Three equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Merit Medical Systems presently has an average rating of “Moderate Buy” and a consensus target price of $103.36. Merit Medical Systems Stock Up 0.3 % MMSI opened at $105.33 on Friday. Merit Medical Systems, Inc. has a fifty-two week low of $65.46 and a fifty-two week high of $106.87. The firm has a market capitalization of $6.14 billion, a P/E ratio of 51.63, a PEG ratio of 2.60 and a beta of 0.89. The company’s 50-day moving average is $98.41 and its 200 day moving average is $90.65. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82. Merit Medical Systems ( NASDAQ:MMSI – Get Free Report ) last posted its earnings results on Wednesday, October 30th. The medical instruments supplier reported $0.86 EPS for the quarter, topping the consensus estimate of $0.80 by $0.06. The firm had revenue of $339.85 million for the quarter, compared to analysts’ expectations of $334.60 million. Merit Medical Systems had a net margin of 9.05% and a return on equity of 15.61%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.75 EPS. Research analysts expect that Merit Medical Systems, Inc. will post 3.36 earnings per share for the current fiscal year. Insider Buying and Selling at Merit Medical Systems In other Merit Medical Systems news, CFO Raul Jr. Parra sold 29,646 shares of the business’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $98.02, for a total value of $2,905,900.92. Following the transaction, the chief financial officer now directly owns 16,361 shares in the company, valued at $1,603,705.22. The trade was a 64.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website . Also, Director F. Ann Millner sold 12,500 shares of the stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $101.55, for a total transaction of $1,269,375.00. Following the transaction, the director now directly owns 32,391 shares of the company’s stock, valued at $3,289,306.05. This represents a 27.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here . Corporate insiders own 3.70% of the company’s stock. Merit Medical Systems Company Profile ( Free Report ) Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. Read More Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter .tilapia fishing

Hail Flutie: BC celebrates 40th anniversary of Miracle in MiamiWorld reaches $300 bn climate finance deal at COP29

While there was high drama in Alexandra Palace on the first day back after the Christmas break, where Damon Heta threw a nine-dart finish, Humphries enjoyed a serene evening. He beat Nick Kenny 4-0 to set up a mouth-watering fourth-round meeting with two-time champion Peter Wright. THE WORLD NUMBER ONE KICKS ON! Luke Humphries comfortably books his spot in the Last 16 with a 4-0 whitewash victory over Nick Kenny, averaging 98.59! 📺 https://t.co/pIQvhqYxEj #WCDarts pic.twitter.com/XAADalXD4Q — PDC Darts (@OfficialPDC) December 27, 2024 Kenny was unable to produce the form that saw him beat Raymond van Barneveld in the previous round and Humphries did not need to be anywhere near his best. “It was one of those games I didn’t want to take for granted,” he said. “I expected a tough game and I wasn’t firing, I felt there is so much more to give, I felt there was more to come out of me. “I didn’t want to give anyone an inch because they can take a mile. “I’m not going to give up this world title without a fight, I wasn’t at my best but when someone pushes me I know I can come up with the goods.” Earlier in the day Heta set the tournament alight on its resumption with a stunning nine-dart finish before bowing out. The Australian, seeded ninth, achieved darting perfection in the second set of his match with Luke Woodhouse to earn a cool £60,000 payday. However, his joy was short-lived as Woodhouse won a thrilling battle 4-3, having trailed 3-1. HEROIC HETA HITS THE NINE! 🔥 UNBELIEVABLE SCENES! 🤯 Damon Heta lands the second nine-darter of the tournament to raise the roof at Alexandra Palace! #WCDarts pic.twitter.com/DW6rhvFqez — PDC Darts (@OfficialPDC) December 27, 2024 Heta was millimetres away from throwing a nine-darter in the previous round when he missed the double 12, but he made no mistake this time in the first match after the Christmas break. Heta’s feat was the second time a nine-darter has been thrown in the 2025 tournament and the 16th of all time at the World Championship, following Christian Kist’s effort before Christmas. As well as landing the Australian a hefty payday, it also saw a lucky fan in Ally Pally win a £60,000, with £60,000 also being donated to Prostate Cancer UK. There were several other titanic battles, none better than Gerwyn Price’s sudden-death leg victory over Joe Cullen. Price looked like he was going to have an easy night when he coasted into a 3-0 lead, but Cullen hit back to send it to a decider, which went all the way. Cullen landed a ‘Big Fish’ 170 checkout to send the tie to a sudden-death leg on his throw but Price hit some big numbers to steal victory. “That was tough, I just wanted to get over the winning line,” he said during his on-stage interview. PRICE WINS A THRILLER! That might just be the game of the tournament so far! 💥 Gerwyn Price manages to break the Rockstars throw in the final leg of the game, and beats Joe Cullen 4-3 and books his place in the Last 16! 📺 https://t.co/pIQvhqYxEj #WCDarts pic.twitter.com/VnjnJxP0T0 — PDC Darts (@OfficialPDC) December 27, 2024 “He kept coming back, the crowd were way behind him. “I thought I was going to lose, but I kept in there right to the end and got the win. “He played some good darts at the right times. I put myself in that position, I got myself out of it and I’m still in.” Seventh seed Jonny Clayton also battled to victory after squandering a 3-0 lead against Daryl Gurney. Gurney then had six darts to send the decider to a tiebreaker but lost his nerve and Clayton stole a 4-3 win. Stephen Bunting and Peter Wright, who was suffering from a chest infection, enjoyed much more safe passages with routine wins over Madars Razma and Jermaine Wattimena respectively.

Fears of a press crackdown under Donald Trump’s second term deepened with his nomination of Kash Patel as FBI director — given his calls for retribution against journalists. Yet a rare chance to protect press freedom has emerged. The bipartisan Protect Reporters from Exploitative State Spying (Press) Act, the strongest press freedom legislation in U.S. history, is on the brink of a vote. While President-elect Trump has urged Republicans to block it, the Senate could still deliver it to Joe Biden before the lame-duck session ends in January. The Press Act would ban secret government demands for journalists’ communications from tech giants such as Google or Verizon and protect reporters from jail for refusing to reveal sources. For investigative reporters to do their jobs — holding government officials to account for corruption and wrongdoing — they need to be able to protect the confidentiality of their sources. With courts recently weakening already-imperilled “reporter’s privilege” protections, this bill would finally give journalists in the U.S. federal protections comparable to those afforded to other relationships where confidentiality is paramount, such as lawyers and clients, doctors and patients, and spouses. The bill has something for both Democrats and Republicans to like. The Press Act’s broad and nonpartisan definition of “journalist” takes into account the modern media landscape: you don’t have to work full-time for a mainstream media organisation to be covered. Freelancers, independent reporters writing Substack newsletters and even journalists posting primarily to social networks such as X would be included. It protects right-leaning journalists just as much as anyone at the New York Times or the Guardian. It also has commonsense national security exceptions (like preventing a terrorist attack or an imminent threat of violence) without diluting the bill’s strong protections. It’s worth remembering that Democratic administrations have abused their powers to go after the first amendment rights of journalists just as much as Republicans. The Obama administration brought a record number of prosecutions against whistleblowers, and was implicated in several government spying scandals, including secretly targeting journalists at the Associated Press and Fox News. Even the Biden administration, before reversing course after public outrage, continued pursuing at least some of the surveillance orders against news outlets that the first Trump administration initiated. That’s why, in an age of extreme political polarisation, the Press Act is about as bipartisan as it gets. The House passed the bill early in 2024 unanimously, with several prominent Republicans publicly touting its importance. The bill also has powerful co-sponsors in the Senate, ranging from Democrats such as Ron Wyden and Dick Durbin, the judiciary committee chair, to Trump-supporting Republicans like Mike Lee and Lindsey Graham. Even the former Fox News host Tucker Carlson supports the bill, as he made clear in a recent interview he did with the former Fox News and CBS reporter Catherine Herridge, who was subpoenaed to reveal a source for a story she wrote several years ago. She was recently in front of the DC court of appeals, where her lawyers argued that forcing reporters to reveal their sources in court sends a chilling effect to countless others around the country.

Previous: filipino fishing
Next: a fishing